Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-02-24 @ 5:02 PM
Study NCT ID:
NCT01321567
Status:
COMPLETED
Last Update Posted:
2023-07-24
First Post:
2011-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis
Sponsor:
Eisai Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PRT11T
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None